Background: The evidence base for the diagnosis and management of amyotrophic lateral
sclerosis (ALS) is weak. Objectives: To provide evidence‐based or expert recommendations …

Amyotrophic lateral sclerosis (known in the UK as motor neuron disease) is a devastating
illness with uncertain pathogenesis. In this Seminar, we review its natural history, clinical …

Background Few patients with amyotrophic lateral sclerosis currently receive non-invasive
ventilation (NIV), reflecting clinical uncertainty about the role of this intervention. We aimed …

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease, leading to
death within an average of 2–3 years. A cure is yet to be found, and a single disease …

Most health-care professionals are trained to promote and maintain life and often have
difficulty when faced with the often rapid decline and death of people with terminal illnesses …

Background Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease, is a
fatal neurodegenerative disease. Neuromuscular respiratory failure is the most common …

Pain is a largely neglected symptom in patients with amyotrophic lateral sclerosis (ALS)
although it is reported by most of these patients. It occurs at all stages of the disease and can …

Dysarthria is a motor disorder of speech characterized by abnormalities of the articulation
and intelligibility of speech. Phonation and the rate of facial movements may also be …

Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease - Ng, L - 2017 |
Cochrane Library Skip to Content Cookies Our site uses cookies to improve your experience …

Despite being one of the most devastating diseases known, there is little evidence for
diagnosing and managing patients with amyotrophic lateral sclerosis (ALS). Although …